MedTrace Logo

ObseRvation After Acute Coronary Syndrome for deveLopment of trEatment Options

NCT04068909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1655

Last updated 2025-12-18

No results posted yet for this study

Summary

The aim of the study is developing an individualized risk model for the unfavorable outcomes of coronary artery disease and complications from ongoing therapy, according to clinical, instrumental, biochemical and genetic parameters in patients with acute coronary syndrome.

Inclusion criteria: patients with acute coronary syndrome (with or without ST elevation) who have indications for PCI Number of inclusion patients - 1655 patients Scheduled time of follow up - 24 month Primary end-point: all-cause death Secondary end-points: any cardiovascular events (cardiovascular death, nonfatal myocardial infarction, non-fatal stroke); non-fatal myocardial infarction; recurrent acute coronary syndrome; non-fatal stoke; complicated atherosclerosis; recurrent PCI; bleeding

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Central State Medical Academy

    lead OTHER

Principal Investigators

  • Dmitry A Zateyshchikov, prof · Central State Medical Academy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-05
Primary Completion
2018-02-20
Completion
2025-10-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04068909 on ClinicalTrials.gov